Literature DB >> 18985644

Protein farnesyltransferase-catalyzed isoprenoid transfer to peptide depends on lipid size and shape, not hydrophobicity.

Thangaiah Subramanian1, Suxia Liu, Jerry M Troutman, Douglas A Andres, H Peter Spielmann.   

Abstract

Protein farnesyl transferase (FTase) catalyzes transfer of a 15-carbon farnesyl group from farnesyl diphosphate (FPP) to a conserved cysteine in the C-terminal Ca(1)a(2)X motif of a range of proteins, including the oncoprotein H-Ras ("C" refers to the cysteine, "a" to any aliphatic amino acid, and "X" to any amino acid) and the lipid chain interacts with, and forms part of the Ca(1)a(2)X peptide binding site. Previous studies have shown that H-Ras biological function is ablated when it is modified with lipids that are 3-5 orders of magnitude less hydrophobic than FPP. Here, we employed a library of anilinogeranyl diphosphate (AGPP) and phenoxygeranyl diphosphate (PGPP) derivatives with a range of polarities (log P (lipid alcohol) = 0.7-6.8, log P (farnesol) = 6.1) and shapes to examine whether FTase-catalyzed transfer to peptide is dependent on the hydrophobicity of the lipid. Analysis of steady-state transfer kinetics for analogues to dansyl-GCVLS peptide revealed that the efficiency of lipid transfer was highly dependent on both the shape and size, but was independent of the polarity of the analogue. These observations indicate that hydrophobic features of isoprenoids critical for their association with membranes and/or protein receptors are not required for efficient transfer to Ca(1)a(2)X peptides by FTase. Furthermore, the results of these studies indicate that the role played by the farnesyl lipid in the FTase mechanism is primarily structural. To explain these results we propose a model in which the FTase active site stabilizes a membrane interface-like environment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18985644      PMCID: PMC3517160          DOI: 10.1002/cbic.200800248

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  58 in total

1.  Non-thiol farnesyltransferase inhibitors: FTase-inhibition and cellular activity of benzophenone-based bisubstrate analogue farnesyltransferase inhibitors.

Authors:  Andreas Mitsch; Silke Bergemann; Ronald Gust; Isabel Sattler; Martin Schlitzer
Journal:  Arch Pharm (Weinheim)       Date:  2003-07       Impact factor: 3.751

2.  Synthesis of 7-substituted farnesyl diphosphate analogues.

Authors:  Diwan S Rawat; Richard A Gibbs
Journal:  Org Lett       Date:  2002-09-05       Impact factor: 6.005

3.  Photolithographic synthesis of peptoids.

Authors:  Shuwei Li; Dawn Bowerman; Nishanth Marthandan; Stanley Klyza; Kevin J Luebke; Harold R Garner; Thomas Kodadek
Journal:  J Am Chem Soc       Date:  2004-04-07       Impact factor: 15.419

4.  Crystallographic analysis of CaaX prenyltransferases complexed with substrates defines rules of protein substrate selectivity.

Authors:  T Scott Reid; Kimberly L Terry; Patrick J Casey; Lorena S Beese
Journal:  J Mol Biol       Date:  2004-10-15       Impact factor: 5.469

5.  NMR characterization of full-length farnesylated and non-farnesylated H-Ras and its implications for Raf activation.

Authors:  Roopa Thapar; Jason G Williams; Sharon L Campbell
Journal:  J Mol Biol       Date:  2004-11-05       Impact factor: 5.469

6.  Crystal structure of protein farnesyltransferase at 2.25 angstrom resolution.

Authors:  H W Park; S R Boduluri; J F Moomaw; P J Casey; L S Beese
Journal:  Science       Date:  1997-03-21       Impact factor: 47.728

7.  Novel farnesol and geranylgeraniol analogues: A potential new class of anticancer agents directed against protein prenylation.

Authors:  B S Gibbs; T J Zahn; Y Mu; J S Sebolt-Leopold; R A Gibbs
Journal:  J Med Chem       Date:  1999-09-23       Impact factor: 7.446

8.  Farnesyl protein transferase: identification of K164 alpha and Y300 beta as catalytic residues by mutagenesis and kinetic studies.

Authors:  Z Wu; M Demma; C L Strickland; E S Radisky; C D Poulter; H V Le; W T Windsor
Journal:  Biochemistry       Date:  1999-08-31       Impact factor: 3.162

9.  Inhibitory effects of mevastatin and a geranylgeranyl transferase I inhibitor (GGTI-2166) on mononuclear osteoclast formation induced by receptor activator of NF kappa B ligand (RANKL) or tumor necrosis factor-alpha (TNF-alpha).

Authors:  Je-Tae Woo; Hiroshi Nakagawa; Annette M Krecic; Kazuo Nagai; Andrew D Hamilton; Said M Sebti; Paula H Stern
Journal:  Biochem Pharmacol       Date:  2005-01-01       Impact factor: 5.858

10.  Protein farnesyltransferase: kinetics of farnesyl pyrophosphate binding and product release.

Authors:  E S Furfine; J J Leban; A Landavazo; J F Moomaw; P J Casey
Journal:  Biochemistry       Date:  1995-05-23       Impact factor: 3.162

View more
  15 in total

1.  Design and synthesis of non-hydrolyzable homoisoprenoid α-monofluorophosphonate inhibitors of PPAPDC family integral membrane lipid phosphatases.

Authors:  Thangaiah Subramanian; Hongmei Ren; Karunai Leela Subramanian; Manjula Sunkara; Fredrick O Onono; Andrew J Morris; H Peter Spielmann
Journal:  Bioorg Med Chem Lett       Date:  2014-08-12       Impact factor: 2.823

2.  Chemoenzymatic reversible immobilization and labeling of proteins without prior purification.

Authors:  Mohammad Rashidian; James M Song; Rachel E Pricer; Mark D Distefano
Journal:  J Am Chem Soc       Date:  2012-05-08       Impact factor: 15.419

3.  Formation of a Novel Macrocyclic Alkaloid from the Unnatural Farnesyl Diphosphate Analogue Anilinogeranyl Diphosphate by 5-Epi-Aristolochene Synthase.

Authors:  Kathleen A Rising; Charisse M Crenshaw; Hyun Jo Koo; Thangaiah Subramanian; Kareem A H Chehade; Courtney Starks; Keith D Allen; Douglas A Andres; H Peter Spielmann; Joseph P Noel; Joe Chappell
Journal:  ACS Chem Biol       Date:  2015-05-04       Impact factor: 5.100

4.  Protein Farnesyltransferase Catalyzes Unanticipated Farnesylation and Geranylgeranylation of Shortened Target Sequences.

Authors:  Sudhat Ashok; Emily R Hildebrandt; Colby S Ruiz; Daniel S Hardgrove; David W Coreno; Walter K Schmidt; James L Hougland
Journal:  Biochemistry       Date:  2020-03-10       Impact factor: 3.162

5.  Selective labeling of polypeptides using protein farnesyltransferase via rapid oxime ligation.

Authors:  Mohammad Rashidian; Jonathan K Dozier; Stepan Lenevich; Mark D Distefano
Journal:  Chem Commun (Camb)       Date:  2010-10-22       Impact factor: 6.222

6.  Identification of a farnesol analog as a Ras function inhibitor using both an in vivo Ras activation sensor and a phenotypic screening approach.

Authors:  Kamalakkannan Srinivasan; Thangaiah Subramanian; H Peter Spielmann; Chris Janetopoulos
Journal:  Mol Cell Biochem       Date:  2013-11-06       Impact factor: 3.396

7.  Novel Citronellyl-Based Photoprobes Designed to Identify ER Proteins Interacting with Dolichyl Phosphate in Yeast and Mammalian Cells.

Authors:  Jeffrey S Rush; Thangaiah Subramanian; Karunai Leela Subramanian; Fredrick O Onono; Charles J Waechter; H Peter Spielmann
Journal:  Curr Chem Biol       Date:  2015

8.  Farnesyl diphosphate analogues with aryl moieties are efficient alternate substrates for protein farnesyltransferase.

Authors:  Thangaiah Subramanian; June E Pais; Suxia Liu; Jerry M Troutman; Yuta Suzuki; Karunai Leela Subramanian; Carol A Fierke; Douglas A Andres; H Peter Spielmann
Journal:  Biochemistry       Date:  2012-10-02       Impact factor: 3.162

9.  Synthesis of Farnesol Analogues Containing Triazoles in Place of Isoprenes through 'Click Chemistry'

Authors:  Thangaiah Subramanian; Sean Parkin; H Peter Spielmann
Journal:  Synlett       Date:  2012-10       Impact factor: 2.454

10.  Site-specific labeling of proteins and peptides with trans-cyclooctene containing handles capable of tetrazine ligation.

Authors:  James W Wollack; Benjamin J Monson; Jonathan K Dozier; Joseph J Dalluge; Kristina Poss; Scott A Hilderbrand; Mark D Distefano
Journal:  Chem Biol Drug Des       Date:  2014-05-13       Impact factor: 2.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.